Iberdomide vs. Observation Post Ide-Cel CAR-T

Iberdomide Versus Observation Off Therapy After Idecabtagene Vicleucel CAR-T for Multiple Myeloma

Near Add Your Location

Huntsman Cancer Institute
University of Utah
Salt Lake City, UT
  • Not currently accepting
Wake Forest Baptist - Comprehensive Cancer Center
Atrium Health
Winston-Salem, NC
  • Not currently accepting
Aurora Cancer Care
Aurora St. Luke's Medical Center
Milwaukee, WI
  • Not currently accepting
UNC Lineberger Comprehensive Cancer Center
University of North Carolina
Chapel Hill, NC
  • Not currently accepting
Memorial Sloan Kettering Bergen
Montvale, NJ
  • Not currently accepting
Alvin J. Siteman Cancer Center
Washington University Medical Campus
St. Louis, MO
  • Not currently accepting
Memorial Sloan Kettering Cancer Center
New York, NY
  • Not currently accepting
  • Show Principal Investigator
Fred Hutchinson Cancer Research Center
University of Washington Cancer Consortium / SCCA
Seattle, WA
  • Not currently accepting
Memorial Sloan Kettering Commack
Commack, NY
  • Not currently accepting
  • Show Principal Investigator

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print a patient-friendly report to share with your patient.

(888) 850-0650

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.